Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PLx Pharma initiates Phase I Aspirin trial
This trial is a randomized, single dose, crossover study that will evaluate the acute safety, tolerability, pharmacokinetics and anti-platelet equivalence of aspirin compared with PL 2100 Aspirin-PC at
This trial is a randomized, single dose, crossover study that will evaluate the acute safety, tolerability, pharmacokinetics and anti-platelet equivalence of aspirin compared with PL 2100 Aspirin-PC at
Micro-K Extencaps capsules are oral dosage forms of microencapsulated potassium chloride containing 600mg of potassium chloride, USP, equivalent to 8 mEq of potassium. Micro-K is indicated for the
Mistral expects to file these products with Health Canada during 2008. The company estimates that these products target a total market of more than $50 million. Dalal Manoli,
The authorities have seized large numbers of counterfeit drugs, mostly fakes of the antimalarial drug artesunate. The investigation is said to have revealed that more than half of
Under the joint development program with Merck, matuzumab has been investigated in Phase II clinical trials in indications such as metastatic colorectal cancer (mCRC), gastric cancer, and non-small
BASF will continue to supply Fortitech with a broad range of nutritional ingredients, but will discontinue its position within the human nutrition premix business. BASF will continue to
Commercial availability of the molecular polymerase chain reaction (PCR) test will enable physicians in the US to test patients who may have contracted the virus, such as individuals
In this study, 33 patients were treated with one of four doses (60, 80, 100 or 120mg/m squared) of picoplatin, as well as either 60mg/m squared or 75mg/m
The technology acquired under the MDC agreement and now owned by the company consists of a platform technology referred to by MDC as DIAAD for the potentially rapid
More than 400 patient-specific Gvax-induced antibody responses were identified in the sera of the treated patients by three different biochemical techniques confirming, as previously reported, that Gvax treatment